Euroapi (XPAR:EAPI) Debt-to-Asset : 0.05 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:EAPI Euroapi SA XPAR:EAPI
59 GF Score
Price €1.28
GF Value €2.88
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Debt-to-Asset?

Euroapi XPAR:EAPI -0.16% 59 Debt-to-Asset is 0.05 as of Dec. 2025. GuruFocus rates XPAR:EAPI with a GF Score™ of 59/100 and a GF Value™ of €2.88 (Possible Value Trap). The stock has 6 warning signs investors should review.

Euroapi's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was €49.1 Mil. Euroapi's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was €16.3 Mil. Euroapi's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2025 was €1,304.7 Mil. Euroapi's debt to asset for the quarter that ended in Dec. 2025 was 0.05.


Euroapi  (XPAR:EAPI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Euroapi Debt-to-Asset Related Terms


Euroapi Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Euroapi's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Debt-to-Asset Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial 0.02 0.07 0.14 0.05 0.05

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.26 0.05 0.05 0.05

XPAR:EAPI vs ZTS, UTHR, VTRS: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroapi Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Euroapi's Debt-to-Asset falls into.


XPAR:EAPI
59GF Score
Euroapi SA XPAR:EAPI
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Euroapi's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Euroapi's Debt-to-Asset for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.05 mean?
Euroapi (XPAR:EAPI) has a Debt-to-Asset of 0.05 as of Dec. 2025. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Euroapi and its competitors.
Is Euroapi's Debt-to-Asset too high?
Euroapi's current Debt-to-Asset is 0.05. Overall, Euroapi has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's Debt-to-Asset compare to ZTS and UTHR?
Euroapi's Debt-to-Asset of 0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Euroapi and its competitors. Euroapi's current Debt-to-Asset is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (XPAR:EAPI) is currently considered Possible Value Trap. The stock's GF Value™ is €2.88, compared to a current price of €1.28 — trading 55.7% below its estimated fair value. The current Debt-to-Asset is 0.05. Euroapi's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Euroapi (XPAR:EAPI), the current Debt-to-Asset is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euroapi (XPAR:EAPI) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €1.28 is trading 55.7% below its estimated GF Value™ of €2.88. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for XPAR:EAPI:

  • Debt-to-Asset: 0.05
  • GF Value™: €2.88 vs. price of €1.28 (55.7% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the XPAR:EAPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Euroapi Business Description

Other Exchanges EAPIF:USA0EAP:UK940:Germany
Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
59GF Score

Get the complete analysis for XPAR:EAPI

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.28
Price
€2.88
GF Value